to evaluate the agreement among self-report, hospital discharge codes, and two different levels of physician review of medical records for cardiovascular endpoints. For myocardial infarction, stroke, pulmonary embolism, and venous thrombosis, the agreement of hospital discharge codes or self-report with review by study physicians at clinical centers was substantial (kappa = 0.64-0.84). For coronary revascularization, agreement among these sources of information was substantial to almost perfect (kappa = 0.79-0.92), but for angina, congestive heart failure, and peripheral vascular disease, concordance was only fair to moderate (kappa = 0.37-0.56), indicating that these endpoints remain difficult to classify reliably. Agreement between physician adjudicators at clinical centers and central physician adjudicators was substantial to almost perfect (kappa = 0.67-0.94). The findings also suggest that, for the endpoint of myocardial infarction, physician review of events with hospital discharge codes for angina and congestive heart failure is an important source of validated events, and for stroke, review of all events with cerebrovascular codes is important.
In clinical trials and observational studies of moderate size, the number of events often is sufficiently small to allow review of each event by several members of an events committee (1, 2) . However, in large multicenter studies involving tens of thousands of participants and multiple endpoints, streamlined methods of endpoint ascertainment are necessary (3) (4) (5) . In some studies, events are adjudicated by study physicians at clinical centers, and all or a portion of events is reviewed by a central adjudicator for quality control purposes (6, 7) . Nonetheless, limited information is available from such studies, particularly from clinical trials, about agreement among sources of diagnoses for cardiovascular events.
The Women's Health Initiative (WHI), a complex clinical investigation of strategies for long-term prevention of common diseases in over 160,000 postmenopausal women at 40 clinical centers, includes a set of clinical trials and an observational study (8) . In the WHI, information on cardio-vascular events is collected from four sources: participant self-report, hospital discharge codes (International Classification of Diseases, Ninth Revision (ICD-9), disease and procedure codes), review of medical records by a physician at the participant's clinical center (local adjudicator, generally one or two physicians at each of 40 centers), and for selected endpoints, review of medical records by one of the 8-10 physician members of the WHI Central Cardiovascular Review Committee (central adjudicator). This setting provides a unique opportunity to evaluate the source of diagnosis information and extent of agreement for cardiovascular endpoints using various methods of ascertainment.
MATERIALS AND METHODS

Setting
The WHI clinical trials, including a total of 68,132 women enrolled during 1993-1998, test whether long-term preventive measures including two distinct regimens of hormone replacement therapy, low-fat diet, and supplementation with calcium and vitamin D decrease the incidence of cardiovascular disease, certain cancers, and fractures. The observational study follows 93,676 postmenopausal women enrolled during 1994-1998 who were ineligible for, or declined enrollment in, the clinical trials (8) . The estrogen-plusprogestin clinical trial was stopped early in July 2002 at the recommendation of the data and safety monitoring board, because the overall risks exceeded the benefits (9) , and the estrogen-only trial was stopped early in March 2004 (10) . The other clinical trials and the observational study continue.
The primary endpoint for the hormone replacement trials was nonfatal myocardial infarction plus coronary heart disease death, and secondary endpoints included hospitalized stroke, angina, coronary revascularization, congestive heart failure, transient ischemic attack, and peripheral vascular disease. While all of these cardiovascular endpoints are also ascertained for all participants in both other clinical trials and the observational study, deep venous thrombosis and pulmonary embolism were safety endpoints ascertained only for the hormone clinical trials.
For the hormone clinical trials, myocardial infarction, stroke, pulmonary embolism, and deep venous thrombosis received both local and central adjudication. In case of disagreement, the WHI protocol calls for review by a second central adjudicator and, if needed, review by committee. The final centrally adjudicated diagnosis for cardiovascular disease reported in study publications for the hormone trials is the diagnosis reached at the end of this review process. For the clinical trials evaluating a low-fat diet and supplementation with calcium and vitamin D, cardiovascular disease is not the primary endpoint. According to WHI protocol, publications reporting results for these two trials will report the centrally adjudicated diagnoses for their primary endpoints (cancers and selected fractures) and the locally adjudicated diagnoses for cardiovascular endpoints. All clinical trial components report the centrally adjudicated cause of death. In observational study publications, the locally adjudicated diagnosis is reported for both cardiovascular endpoints and fatal events. Nonetheless, during the early years of the study covered by this analysis, myocardial infarction, angina, congestive heart failure, coronary bypass, and angioplasty received both local and central adjudication for both the clinical trials and the observational study, permitting an evaluation of the extent of agreement across all study components.
Data collection and adjudication
Informed consent was obtained from participants, and the institutional review boards of the study centers approved the study protocol. Participants or their proxies completed standardized questionnaires, every 6 months for clinical trial participants and every year for observational study participants, that asked about all hospitalizations, outpatient coronary revascularization, and outpatient diagnosis of deep venous thrombosis since the last update. Potential events were identified from these participant self-reports of hospitalizations and selected outpatient diagnoses. For a specified list of common procedures and conditions not of interest to the study, no hospital records were requested. For all other events, medical records were requested from the hospital or outpatient facility and death certificates were obtained from the state or the family, and these records were reviewed by the local adjudicator. Elements of the medical record requested included hospital discharge codes, the discharge summary, laboratory studies, electrocardiograms, diagnostic test reports, and procedure reports. Hospital discharge codes were provided for 63 percent of events for which medical records were requested and received.
The local adjudicator was not the participant's personal physician and, for clinical trial participants, was blinded to randomization assignment. For all potential events evaluated in this analysis (except stroke and peripheral vascular disease events), if the local adjudicator identified a cardiovascular event meeting WHI study definitions, the medical records were forwarded to a WHI central adjudicator. Central adjudicators are members of the WHI Central Cardiovascular Review Committee, which establishes procedures for adjudication and meets periodically to review difficult cases. In addition, for this analysis, the interrater agreement between central adjudicators was assessed in a subset of 81 cardiovascular cases that were reviewed by two central adjudicators. The WHI criteria for cardiovascular endpoints were adapted from standardized criteria and are reported elsewhere (11) .
Statistical analysis
Included in this analysis were all participant reports for any WHI endpoint, including noncardiovascular endpoints, from both the clinical trials and the observational study, on which processing was complete between January 1, 1994, and November 30, 2000. There was a lag between the event date and the close of processing, and the sample included only reports on which processing was complete. Cardiovascular events of interest included first episodes after study enrollment of fatal or nonfatal myocardial infarction, angina, congestive heart failure, occurrences of coronary artery bypass graft and coronary angioplasty, stroke, transient ischemic attack, peripheral vascular disease, and, for the hormone trials only, the safety endpoints of pulmonary embolism or deep venous thrombosis. A particular woman could appear more than once in the analysis if, for example, she reported a first myocardial infarction as well as a first stroke during the period of analysis. The proportion of women reporting a history of myocardial infarction at enrollment was 2.1 percent in the clinical trials and 2.5 percent in the observational study; for stroke the comparable numbers were 1.1 percent and 1.5 percent, and for deep venous thrombosis or pulmonary embolism they were 3.2 percent and 4.4 percent.
We evaluated positive predictive value (proportion of positives reported by the test method that were verified by the reference method), sensitivity (proportion of positives reported by the reference method that were also reported as positives by the test method), and specificity (proportion of negatives reported by the reference method that were also reported as negatives by the test method) as measures of validity. We used the kappa statistic with exact binomial 95 percent confidence intervals as a measurement of the extent of agreement beyond chance alone (12) . Kappa values of 0.81-0.99 were considered to represent almost perfect agreement and of 0.61-0.80 substantial, 0.41-0.60 moderate, and 0.21-0.40 fair agreement (13) . Because of the relative rarity of cardiovascular endpoints among all the potential events reported by participants, in analyses that assessed agreement of hospital discharge codes and self-report with local adjudication, specificity was over 99 percent with very narrow 95 percent confidence intervals, except as noted in the text.
RESULTS
Comparison of hospital discharge codes with local adjudication
Between January 1, 1994, and November 30, 2000, there were 34,016 participant reports of events on which processing was complete and where hospital discharge codes (ICD-9 disease and/or procedure codes) were requested and available. The agreement between selected ICD-9 codes and local adjudicator diagnosis was examined, with the local adjudicator opinion used as the reference method (table 1) . The proportion of events with an ICD-9 code indicating myocardial infarction (code 410) or cardiac arrest (codes 427.4 and 427.5) that were verified as myocardial infarction by the local adjudicator (the positive predictive value) was 78 percent. The sensitivity of the selected ICD-9 codes for myocardial infarction overall was 80 percent, and the specificity was 99.4 (95 percent confidence interval (CI): 99.3, 99.5) percent. The kappa statistic was 0.78. There were 169 events identified by the local adjudicator as myocardial infarction that did not have a code of 410 or 427.4-427.5; most of these events had a code indicating angina (n = 132), congestive heart failure (n = 10), or other cardiovascular disease (n = 11). Agreement was also substantial for stroke and for the safety endpoints of pulmonary embolism and deep venous thrombosis. The 127 events identified by the local adjudicator as a stroke that did not have one of the listed stroke codes were coded as transient ischemic attack (code 435; n = 23) or as another cerebrovascular disease (code 433, 437, or 438; n = 58), or they had no cerebrovascular disease code (n = 46). For angina, congestive heart failure, and peripheral vascular disease, the positive predictive value and kappa statistics were considerably lower than for myocardial infarction or stroke, and the specificities were 93, 98, and 99 percent, respectively. By contrast, all indices of agreement were quite high for both types of coronary revascularization.
Comparison of self-report with local adjudication
Concordance between self-reported cardiovascular endpoints and local adjudicator diagnosis, used as the reference method, was compared for all 99,500 participant reports on which processing was complete, regardless of whether hospitalization records were requested or hospital discharge codes received (table 2) . For self-reports of cardiovascular disease, hospitalization records were always requested. Stroke and transient ischemic attack are combined because participants were asked a single question about both conditions. The proportion of self-reported events verified by the local adjudicator (positive predictive value) was 58-75 percent for myocardial infarction, congestive heart failure, angioplasty, stroke/transient ischemic attack, peripheral vascular disease, and deep venous thrombosis, but it was considerably lower (37 percent) for angina. By contrast, selfreports of coronary bypass surgery and pulmonary embolism had high rates of verification by local adjudicators (positive predictive values: 90 and 86 percent, respectively). The kappa statistics for agreement between self-report and local adjudication for angina, congestive heart failure, and peripheral vascular disease were 0.37, 0.48, and 0.53, respectively.
Source of diagnosis for events identified by local adjudication
Among the 34,016 participant reports of events on which processing was complete and where hospital discharge codes were requested and available during the study period, there were 11,272 participant reports where the self-report, the hospital discharge code, or the local adjudicator identified a cardiovascular event. Considering local adjudication as the reference method, the source of the diagnosis for various cardiovascular endpoints is shown in table 3. For example, for myocardial infarction, of the 847 events judged to meet WHI criteria by the local adjudicator, 55 percent were identified by all three sources: self-report, hospital discharge code, and the local adjudicator; 6 percent by self-report and the local adjudicator; 25 percent by hospital discharge code and the local adjudicator; and 14 percent by the local adjudicator only (an event was identified during a hospitalization without a hospital discharge code for myocardial infarction, and a myocardial infarction was not reported by the participant). A total of 39 percent of myocardial infarction events identified by the local adjudicator were not identified by self-report. For angina and congestive heart failure, around 60 percent of the events identified by the local adjudicators were not identified by self-report, and for peripheral vascular disease, the number was 48 percent. Conversely, there were large numbers of events with hospital discharge codes indi-cating angina, congestive heart failure, and peripheral vascular disease that were determined not to meet WHI criteria for these cardiovascular events by local adjudicators.
Comparison of local and central adjudication
Local adjudication and the initial central adjudication were complete on 3,634 cardiac events and 144 pulmonary embolism or venous thrombosis events identified by the local adjudicators (table 4) . Peripheral vascular disease is not centrally adjudicated in WHI, and during the period covered by this analysis, stroke/transient ischemic attack was not yet centrally adjudicated; therefore these endpoints do not appear in table 4. The agreement between local and central adjudication as measured by the kappa statistic was 0.79-0.94 for myocardial infarction, congestive heart failure, both types of revascularization, and the safety endpoints of pulmonary embolism and venous thrombosis, but it was 0.67 for angina. Central adjudication identified fewer events of all types than did local adjudication. To assess the interrater agreement between central adjudicators, two separate central adjudicators conducted reviews in a subset of 81 cardiac events; the kappa statistics were 0.81 for myocardial infarction, 0.65 for angina, 0.71 for congestive heart failure, 0.92 for coronary bypass surgery, and 0.81 for angioplasty. Local and central adjudications were compared for 1,518 deaths. With the initial central adjudication as the reference method, for the endpoint of death due to definite or possible coronary heart disease, the positive predictive value was 80 
DISCUSSION
In the WHI, the use of hospital discharge codes or selfreport to identify cardiovascular events without local adjudication resulted in some misclassification of myocardial infarction, stroke, pulmonary embolism, and venous thrombosis, as well as considerable misclassification of angina, congestive heart failure, and peripheral vascular disease. On the other hand, the use of procedure codes to identify coronary revascularization procedures, particularly coronary bypass surgery, appeared to be reasonably accurate and complete. 847  466  55  48  6  212  25  121  14  314  41  154  119   Angina  1,709  643  38  55  3  890  52  121  7  2,430  382  1,899  149   Congestive heart failure  795  276  35  28  4  352  44  139  18  825  58  699  68   Coronary bypass  647  527  82  56  9  49  8  15  2  137  20  9  108   Angioplasty  937  695  74  97  10  110  12  35  4  209  32  16  161   Stroke  709  517  73  97  14  65  9  30  4  314  64  74  176   Transient ischemic attack  438  241  55  69  16  78  18  50  11  210  66  56  88   Peripheral vascular disease  199  82  41  22  11  39  20  56  28  296  5  266  25   Pulmonary embolism  61  40  66  8  13  10  16  3  5  22  0  8  14   Deep venous thrombosis  121  83  69  12  10  21  17  5  4  52  9  26  17 Agreement was very good to excellent between local and central adjudicators for all cardiovascular endpoints studied. Concordance was best for myocardial infarction, congestive heart failure, coronary bypass surgery, angioplasty, pulmonary embolism, and venous thrombosis but was less substantial for angina. For the underlying cause of death, agreement between local and central adjudicators was very good to excellent for deaths due to combined definite or possible coronary disease and for deaths due to cerebrovascular disease.
Strengths of this analysis include the large numbers of outcomes investigated, the extensive and detailed follow-up of participants, the completeness of the data, the representation of participants from a wide variety of US communities, and the ability to report the source of diagnosis for events verified by local adjudication. The WHI included relatively few women with low socioeconomic status or from rural areas, and it did not include men. Thus, the results reported here might not be generalizeable to these groups. Hospital discharge codes were available for only 63 percent of selfreported events for which medical records were received. Thus, conclusions about agreement of hospital discharge codes with local adjudicator diagnosis might be biased if missing discharge code data did not occur at random. In this study, nonfatal cardiovascular events other than venous thrombosis and angioplasty were limited to those resulting in hospitalization. Thus, our analysis did not include outpatient events or events that were not clinically recognized. For the assessment of agreement between local and central adjudication, only those events identified by local adjudicators were forwarded for further review by central adjudicators during the period of this analysis. Self-reported events found not to meet WHI criteria for events by local adjudicators were not forwarded for central adjudication. This screening process could have affected the estimates of validity and agreement for the comparison of local and central adjudication. The number of pulmonary embolism and venous thrombosis events was small because they were ascertained in only the hormone therapy trials, and findings for these safety endpoints should be interpreted with caution. Finally, information about the circumstances of death in WHI was generally limited to the death certificate and records from the most recent hospitalization during the study; informant interviews were available for only a small proportion of fatal cases. Using information on the circumstances of death from medical records and interviews with a variety of informants, including physicians and medical examiners, the Atherosclerosis Risk in Communities Study documented that coronary disease is listed as the cause of death on death certificates more often than is supported by the evidence (14) , a finding that has been observed in other studies (15) .
The extent of agreement between hospital discharge codes and physician adjudicator review for various cardiovascular endpoints was similar in the WHI and the Cardiovascular Health Study (1), both of which used self-report as the starting point for investigating events and used very similar criteria for defining cardiovascular events. Several other studies have reported the extent of agreement between hospital discharge codes and physician review for the endpoint of myocardial infarction (4, (16) (17) (18) . Although the positive predictive value of ICD-9 code 410 for myocardial infarction was uniformly quite high in these studies (range: 79-90 percent), the sensitivity varied considerably (range: 36-89 percent), possibly related to differences in the range of ICD-9 codes investigated and varying criteria for myocardial infarction. As in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, the number of coronary disease events identified in the WHI increased as more sources of data were used (19) . Across all hospital discharge codes corresponding to stroke, the positive predictive value was 90 percent in the Cardiovascular Health Study and 81 percent in the WHI. Similar results have been reported for stroke from Saskatchewan (20) .
For the two hormone clinical trials in WHI, the final centrally adjudicated diagnosis for cardiovascular endpoints reported in study publications is the diagnosis reached after the initial central review and any additional central review required because of disagreement with the local adjudicator. Since a fraction of central reviews initially discordant with the local adjudication are overturned by subsequent central reviews, the extent of agreement with local adjudication is higher for the final central diagnosis than for the initial central diagnosis, as was observed in this analysis for deaths due to coronary disease. In the WHI estrogen-plus-progestin trial, the reported positive predictive value for local adjudication as compared with central adjudication was 90 percent for myocardial infarction and 97 percent for death due to definite or possible coronary disease (21) . These rates compare favorably with those from other large multicenter trials, such as the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), in which the reported positive predictive value for local adjudication as compared with central adjudication was 92 percent (72 of 78 events; 95 percent CI: 84, 97) for the composite endpoint of nonfatal myocardial infarction and fatal coronary heart disease (6).
In very large studies, cost-effective adjudication of cardiovascular endpoints is a challenge. Findings from the WHI suggest that, for the endpoint of myocardial infarction, physician review of events with hospital discharge codes for angina and congestive heart failure is an important source of validated events, and for stroke, review of all events with cerebrovascular codes is important. For coronary bypass, agreement was excellent for both self-report and hospital discharge codes, with physician review of medical records suggesting that any of these sources of information could be used; however, for angioplasty, agreement of self-report with local adjudication was slightly lower than for coronary bypass. For the clinical syndromes of angina and congestive heart failure and for peripheral vascular disease, concordance among the various sources of information was only fair to good, suggesting that these endpoints remain difficult to classify reliably. These findings may prove useful to investigators planning large-scale investigations with cardiovascular endpoints.
